Current Infectious Disease Reports
Scope & Guideline
Connecting Scholars to the Pulse of Infectious Disease Trends
Introduction
Aims and Scopes
- Infectious Disease Epidemiology:
The journal covers trends, outbreaks, and epidemiological studies related to various infectious diseases, helping to understand their spread and impact on populations. - Clinical Management and Therapeutics:
It emphasizes advancements in treatment strategies, including novel therapies and management protocols for infectious diseases, ensuring practitioners are informed about the latest clinical guidelines. - Antimicrobial Stewardship and Resistance:
A core focus is on antimicrobial resistance, exploring stewardship practices, resistance patterns, and the development of new therapeutic agents to combat resistant infections. - Infection Prevention and Control:
The journal provides insights into best practices for infection prevention in various settings, highlighting innovative approaches to reduce healthcare-associated infections. - Global Health Perspectives:
It addresses infectious diseases from a global perspective, emphasizing challenges faced in low- and middle-income countries, and the impact of social determinants on health.
Trending and Emerging
- Emerging Viral Infections:
A significant uptick in research addressing emerging viruses such as MPox and Marburg highlights the journal's commitment to understanding and managing new health threats. - Impact of Climate Change on Infectious Diseases:
Recent publications exploring the relationship between climate change and infectious disease outbreaks indicate an emerging focus on environmental health and its implications for infectious disease epidemiology. - Invasive Fungal Infections:
There is a growing interest in the management and treatment of invasive fungal infections, particularly in immunocompromised populations, reflecting broader concerns about fungal resistance and diagnostics. - Artificial Intelligence in Infection Management:
The integration of AI and advanced technologies in managing and predicting infectious disease outcomes is gaining traction, showcasing the journal's openness to innovative approaches. - Antimicrobial Resistance and New Therapeutics:
Research on antimicrobial resistance remains a priority, with an increased emphasis on developing new therapeutic agents and strategies to combat resistant infections.
Declining or Waning
- Traditional Antiviral Therapies:
There is a noticeable decrease in publications focused on conventional antiviral medications, possibly due to the rise of novel therapies and the urgency of addressing emerging viruses. - General Pediatric Infectious Diseases:
Research specifically addressing common pediatric infections appears to be waning, as the focus has shifted towards more complex cases and emerging threats in pediatric populations. - Surgical Infections and Postoperative Complications:
The frequency of articles detailing traditional surgical site infections and management strategies has declined, indicating a potential shift towards more innovative or preventive approaches. - Travel-related Infectious Diseases:
While still relevant, the volume of articles specifically addressing travel-related infections has decreased, perhaps due to changes in travel patterns and public health responses to recent pandemics. - Non-Communicable Diseases Related to Infectious Agents:
Research linking infectious diseases to non-communicable diseases (e.g., cancers related to viral infections) has seen less focus, possibly overshadowed by more immediate infectious disease challenges.
Similar Journals
International Journal of Antimicrobial Agents
Pioneering Insights into Antimicrobial Efficacy and SafetyInternational Journal of Antimicrobial Agents, published by Elsevier, stands as a premier platform in the fields of Infectious Diseases, Microbiology, and Medical Pharmacology. With an impressive impact factor and ranked in the Q1 category across multiple medical disciplines in 2023, this journal is recognized for its contribution to advancing knowledge and understanding in the efficacy and safety of antimicrobial treatments. Its comprehensive scope from 1991 to 2024 allows for the publishing of original research, reviews, and commentary on pressing issues related to antimicrobial resistance, treatment strategies, and pharmacological innovations. With a strong emphasis on high-quality research as reflected in its Scopus rankings, the journal is an essential resource for researchers, clinicians, and students dedicated to improving patient outcomes in the face of evolving microbiological challenges. Engage with the latest findings and methodologies through this vital academic resource, available in print and online, from the heart of the Netherlands.
Journal of Infection Prevention
Elevating healthcare standards with cutting-edge insights.Journal of Infection Prevention, published by SAGE Publications Ltd, is a pivotal resource in the fields of nursing, public health, and infectious diseases. With an ISSN of 1757-1774 and an E-ISSN of 1757-1782, this journal primarily serves as a platform for disseminating innovative research and comprehensive reviews aimed at enhancing infection control practices and health policy formulation. As of 2023, it holds a prestigious position within category quartiles, ranking Q2 in Advanced and Specialized Nursing and Q3 in Health Policy, Infectious Diseases, as well as Public Health, Environmental and Occupational Health, underscoring its relevance and influence in these arenas. Researchers, practitioners, and students are encouraged to explore the journal's content to contribute to the advancement of infection prevention strategies and the overall improvement of healthcare systems. With a convergence timeline from 2009 to 2024, the Journal of Infection Prevention is committed to publishing high-quality articles that address current challenges in infection control, thus playing a crucial role in the ongoing dialogue among health professionals.
Infection Prevention in Practice
Bridging research and practice in infectious disease management.Infection Prevention in Practice is a leading academic journal published by ELSEVIER that has established itself as a vital resource in the domains of Infectious Diseases and Public Health. With its Open Access policy implemented since 2019, the journal enhances global accessibility to cutting-edge research and practical insights aiming to reduce the risk of infections in various settings. It proudly holds a Q3 ranking in Infectious Diseases and a Q2 ranking in Public Health, Environmental and Occupational Health as of 2023, showcasing its impact and relevance within the scientific community—particularly with a Scopus rank placing it in the 71st percentile for public health research. Its scope includes the latest advancements, strategies, and practices in infection prevention, making it an indispensable read for researchers, healthcare professionals, and students dedicated to improving health outcomes and combating infectious diseases effectively. The journal operates from its base in the United Kingdom and reaches a global audience, fostering collaboration and innovation in infection control practices.
Infektsiya i Immunitet
Bridging research and practice for a healthier future.Infektsiya i Immunitet, published by the esteemed SANKT-PETERSBURG-NIIEM IMENI PASTERA, is a prominent open access journal that has been disseminating vital research findings since 2011. Focusing on the fields of immunology and infectious diseases, this journal serves as a critical platform for scholars, professionals, and students in the Russian Federation and beyond. With an ISSN of 2220-7619 and an E-ISSN of 2313-7398, it currently holds a Q4 ranking in 2023 for both Immunology and Infectious Diseases, along with notable quartile standings in related fields. Despite its emerging status, Infektsiya i Immunitet provides valuable insights and contributes to the growing discourse on immunity and infection prevention strategies, making it an essential resource for those invested in advancing knowledge and enhancing public health outcomes. Researchers can conveniently access its wealth of articles and studies that bridge theoretical understanding and practical implications in their respective domains.
Revista de Epidemiologia e Controle de Infeccao
Empowering Global Health with Open Access InsightsRevista de Epidemiologia e Controle de Infeccao, published by Universidade de Santa Cruz do Sul, stands as a vital resource for scholars and practitioners in the fields of epidemiology and infection control. This open-access journal, available since 2011, fosters the dissemination of high-quality research and practice-based knowledge aimed at enhancing public health and improving infection management strategies. With its commitment to sharing invaluable insights from Brazil and beyond, the journal encourages broader participation in critical discussions surrounding infectious diseases. Although specific metrics such as the HIndex and Scopus rankings are currently omitted, the journal's relevance is underscored by its open accessibility, allowing a global audience of researchers, healthcare professionals, and students to engage with innovative studies and findings in this essential area of public health.
Infectious Diseases and Clinical Microbiology
Advancing knowledge in infectious diseases and microbiology.Infectious Diseases and Clinical Microbiology is a pivotal journal dedicated to advancing our understanding of infectious diseases through rigorous scientific research and clinical practices. Published by DOC DESIGN INFORMATICS CO LTD, this journal serves as a vital platform for researchers, healthcare professionals, and students keen on enhancing their knowledge of microbiological sciences and the clinical implications of infectious agents. With an ISSN of 2667-646X, it aims to disseminate significant findings in the field, enriching the scholarly dialogue surrounding infectious diseases. While currently operating under a traditional access model, the journal encourages global collaboration and knowledge sharing, striving to make a meaningful impact in tackling the challenges posed by infectious diseases. Its content aims to bridge the gap between laboratory research and clinical application, making it an essential resource in the contemporary landscape of global health.
JOURNAL OF INFECTION AND CHEMOTHERAPY
Elevating Standards in Infectious Disease ScholarshipJOURNAL OF INFECTION AND CHEMOTHERAPY, published by Elsevier, is a leading journal in the fields of Infectious Diseases, Microbiology, and Pharmacology. With a solid reputation reflected in its prestigious Q2 ranking in Infectious Diseases and Pharmacology, and Q3 in Microbiology (medical), this journal serves as a vital resource for researchers, clinicians, and students interested in the latest advancements in the diagnosis, treatment, and prevention of infectious diseases. The journal provides a platform for high-quality, peer-reviewed scholarly articles, making it an essential reference point in the medical community. Despite being published without open access, it continues to attract significant scholarly attention, as denoted by its rankings in Scopus, which showcases its impact within the academic landscape. With a timeline converging from 1995 to 2024, JOURNAL OF INFECTION AND CHEMOTHERAPY is dedicated to advancing knowledge and contributing to better health outcomes globally.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
Connecting Research with Real-World Healthcare SolutionsINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, published by Cambridge University Press, is a leading academic journal specializing in the critical fields of epidemiology, infectious diseases, and medical microbiology. With a history of publication dating back to 1988 and an expected continuation through 2024, the journal has established itself as a pivotal resource for researchers, healthcare professionals, and students alike. The journal's impact is reflected in its impressive rankings, positioning it in the second quartile for Epidemiology and the first quartile for both Infectious Diseases and Medical Microbiology as of 2023. This esteemed journal is dedicated to the dissemination of high-quality research that informs best practices in infection control and enhances patient safety across healthcare settings. Although access to its content is not open, the rigorous peer-review process ensures that all published articles contribute significantly to the body of knowledge in these vital areas. With a commitment to bridging the gap between research and practice, INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY remains an essential publication for those committed to the advancement of public health and the science of infection prevention.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
Leading the Charge in Infectious Disease ScholarshipINFECTIOUS DISEASE CLINICS OF NORTH AMERICA, published by W B SAUNDERS CO-ELSEVIER INC, stands as a premier academic resource in the field of infectious diseases and microbiology. With its ISSN 0891-5520 and E-ISSN 1557-9824, this esteemed journal has been at the forefront of disseminating critical research findings and clinical advancements since its inception in 1987. Known for its high impact, the journal ranks in the Q1 category for both Infectious Diseases and Medical Microbiology as of 2023, which underscores its significant contribution to advancing knowledge and practice in these vital areas. Researchers, practitioners, and students alike rely on its comprehensive yet concise reviews and original articles, ensuring they stay abreast of emerging trends and therapeutics in infectious disease management. Although it does not offer open access, the journal remains pivotal in enriching scholarly dialogue and influencing clinical practices in the United States and beyond. Explore this vital publication and join a community dedicated to excellence in infectious disease research.
BMC INFECTIOUS DISEASES
Connecting researchers to the forefront of infectious disease science.BMC Infectious Diseases is a premier open-access journal published by BMC in the United Kingdom, dedicated to the field of infectious diseases. Established in 2001, this journal has been at the forefront of disseminating high-quality, peer-reviewed research, contributing significantly to the global understanding of infectious pathogens and their impact on public health. With a 2023 Scopus ranking of #100 out of 344 in the Medicine - Infectious Diseases category, and a notable Q1 quartile classification, it stands as a vital resource for researchers and professionals alike. Authors benefit from the journal's broad reach and visibility, ensuring their work is accessible to a wide audience. Access options are fully open, allowing for seamless dissemination of knowledge in the ongoing battle against infectious diseases. With an established history of publishing groundbreaking studies, BMC Infectious Diseases plays a crucial role in addressing critical issues and advancing research in the ever-evolving landscape of infectious diseases.